Evidence map›Paper›PMID 31665230›Full record

ArticleBrain : a journal of neurology2019

Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.

Darius Häusler, Sebastian Torke, Evelyn Peelen, Thomas Bertsch, Marija Djukic, Roland Nau, Catherine Larochelle, Scott S Zamvil, Wolfgang Brück, Martin S Weber

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Darius HäuslerInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Sebastian TorkeInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Evelyn PeelenDepartment of Neurosciences, Centre de recherche de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Thomas BertschInstitute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, General Hospital Nuremberg, Paracelsus Medical University, Nuremberg, Germany.
Marija DjukicInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Roland NauInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Catherine LarochelleDepartment of Neurosciences, Centre de recherche de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Scott S ZamvilDepartment of Neurology, University of California, San Francisco, CA, USA.
Wolfgang BrückInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Martin S WeberInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Centre Hospitalier de l’Université de Montréal · CAEvangelisches Krankenhaus Göttingen-Weende · DEUniversitätsmedizin Göttingen · DEUniversity of Göttingen · DENuremberg Hospital · DEUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HypercalcemiaMultiple SclerosisCholecalciferolDietary SupplementsHumansVitamin DCholecalciferolVitamin D

Identifiers

PMID31665230
PMCPMC6906588
OpenAlexW2982312718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.